tirzepatide glen carbon GLP-1/GIP Rx Tirzepatide: A Systematic Update

22 May 2026 A Correction to this paper has been published: Abbreviations RA: Rheumatoid Arthritis GLP-1RAs: Glucagon-like peptide-1 receptor agonists GLP-1R: Glucagon-like peptide-1 receptor MNs: Microneedles FLS: Fibroblast-like synoviocytes HAMA: Hyaluronic Acid Methacrylate NPs: Nanoparticles mtDNA: mitochondrial DNA TNF-: Tumor necrosis factor- IL-1: Interleukin-1 IL-6: Interleukin-6 KEGG: Kyoto encyclopedia of genes and genomes GO: Gene ontology GSEA: Gene set enrichment analysis cGAS: Cyclic GMP-AMP synthase STING: Stimulator of interferon genes References Hemant S, Mukesh Kumar AD, Vaishali K, Deepak P, Ajeet SC, Dhiraj K, Rohit BS, Mukesh D

A simple blood test may be able to identify specific vitamin and mineral deficiencies

Clinical criteria apply

You can be confident that were committed to helping you get your life back on track

At Health Express Clinics , we prescribe either based on: Primary diagnosis (type 2 diabetes vs obesity) Insurance eligibility Response to prior treatments like semaglutide What the Research Says Tirzepatide Results Here are key findings from recent studies: SURMOUNT-1 Trial (NEJM, 2022): Adults lost 22.5% of body weight over 72 weeks More effective than semaglutide at equivalent durations JAMA (2023): Tirzepatide showed significant improvements in A1c, triglycerides, and waist circumference Participants reported higher satisfaction and adherence compared to other weight loss medications Lancet Diabetes & Endocrinology (2023): Tirzepatide consistently outperformed other medications in head-to-head comparisons These are not just cosmetic results